Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-29

Clinical Trial Update: Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer [NA]

View source ↗

Summary

A completed clinical trial suggests that pronase improves the efficacy of chromoendoscopy screening for esophageal neoplasms (esophageal cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pronase (Pronase)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Esophageal Neoplasms | NA | Status: COMPLETED